4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-20-064657
Options or other derivatives
- CEO acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| LEVIN JEREMY M CEO | 2020-12-17 | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | D | ||
Loading xslF345X03/doc4.xml…